You are here: Industry Insights > Lilly

News List

Lilly to Present Data for Galcanezumab for the Prevention of Migraine at the American Academy of Neu lilly
April 21, 2017
Eli Lilly and Company (NYSE: LLY) will highlight Phase 2 data evaluating galcanezumab for the prevention of migraine at the American Academy of Neurology (AAN) annual meeting, which will take place April 22-28, 2017, in Boston.
From bench to bedside – and back lilly
April 14, 2017
This article is from Susan Forda, Vice-President of Global Regulatory Affairs International at Lilly.
Lilly Confirms Date and Conference Call for First-Quarter 2017 Financial Results Announcement lilly
April 12, 2017
Eli Lilly and Company (NYSE: LLY) will announce its financial results for the first quarter of 2017 on Tuesday, April 25, 2017.
Improving and extending the lives of patients with advanced breast cancer lilly
April 11, 2017
This article comes from Fatima Cardoso, Chair ABC Global Alliance, on behalf of all members
Life with Type 1 Diabetes Made a Little Easier through Lilly Diabetes Scholarship Donations for Camp lilly
April 10, 2017
Living with type 1 diabetes comes with many unique challenges in all stages of life. For parents of children with the condition, financial, medical and emotional worries can be overwhelming.
Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for M lilly
April 05, 2017
Students from Ohio University's Heritage College of Osteopathic Medicine will soon join Eli Lilly and Company's (NYSE: LLY) innovative rotation program for aspiring physicians.
Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017 lilly
March 27, 2017
Significant investment in manufacturing diabetes medicines continues with new $85 million commitment in Indianapolis $5 billion invested in its U.S. operations over the last decade; more favorable tax climate could lead to additional U.S. investments
Lilly and the William Sansum Diabetes Center announce a five-year research collaboration lilly
March 27, 2017
Jointly developed research projects will study diabetes healthcare outcomes for the Latino population
WNIF: Combating Alzheimer’s Together lilly
March 23, 2017
This article comes from Phyllis Ferrell, Lilly’s vice president and platform development leader for the global Alzheimer’s disease team.
Lilly Announces Phase 3 MONARCH 2 Breast Cancer Study of Abemaciclib Met Primary Endpoint of Progres lilly
March 21, 2017
Abemaciclib, in combination with fulvestrant, was superior to fulvestrant plus placebo in patients with HR+, HER2- advanced breast cancer

Previous page 1 2 3 4 5 6 7 8 9 10 ... 25 26 Next page